C43H51N19O3 — CID 159683945
3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]propan-1-one;[(2S)-1-methylpyrrolidin-2-yl]methanamine (PubChem CID 159683945) has the molecular formula C43H51N19O3 and a molecular weight of 882.01 g/mol. Its IUPAC name is 3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]propan-1-one;[(2S)-1-methylpyrrolidin-2-yl]methanamine.
| Compound Name | 3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]propan-1-one;[(2S)-1-methylpyrrolidin-2-yl]methanamine |
|---|---|
| PubChem CID | 159683945 |
| Molecular Formula | C43H51N19O3 |
| Molecular Weight | 882.01 g/mol |
| Exact Mass | 881.44 |
| IUPAC Name | 3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylbenzimidazol-5-yl)-5-(triazol-2-yl)pyrazin-2-yl]-3-[(2S)-1-methylpyrrolidin-2-yl]propan-1-one;[(2S)-1-methylpyrrolidin-2-yl]methanamine |
| SMILES | CN1CCC[C@H]1CCC(=O)c1nc(-c2ccc3ncn(C)c3c2)c(-n2nccn2)nc1N.CN1CCC[C@H]1CN.Cn1cnc2ccc(-c3nc(C(=O)O)c(N)nc3-n3nccn3)cc21 |
| InChI | InChI=1S/C22H25N9O.C15H12N8O2.C6H14N2/c1-29-11-3-4-15(29)6-8-18(32)20-21(23)28-22(31-25-9-10-26-31)19(27-20)14-5-7-16-17(12-14)30(2)13-24-16;1-22-7-17-9-3-2-8(6-10(9)22)11-14(23-18-4-5-19-23)21-13(16)12(20-11)15(24)25;1-8-4-2-3-6(8)5-7/h5,7,9-10,12-13,15H,3-4,6,8,11H2,1-2H3,(H2,23,28);2-7H,1H3,(H2,16,21)(H,24,25);6H,2-5,7H2,1H3/t15-;;6-/m0.0/s1 |
| InChIKey | MVNYCKYEGFFRFE-GPVZQKFCSA-N |
| XLogP | 3.18 |
| TPSA | 287.53 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 65 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 882.01 |
| LogP ≤ 5 | 3.18 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 21 |